It is thus presumed that preferential targeting of GluN1-GluN2A/B NMDARs would be a more appropriate approach in regard to alleviating ADHD symptoms, and these types of the receptor should be given the most attention in further studies. Here, GRIN1 is linked to attention deficit-hyperactivity disorder.